Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye

Korean J Ophthalmol. 2007 Dec;21(4):189-94. doi: 10.3341/kjo.2007.21.4.189.

Abstract

Purpose: To compare the short term effects of topical 0.05% cyclosporine (CsA) and a mixture of 0.08% chondroitin sulfate and 0.06% sodium hyaluronate (CS-HA) on dry eye ocular surfaces.

Methods: 36 patients with moderate to severe dry eye (5 mm/5 min or less with Schirmer's test or tear break up time (BUT) less than 6 seconds), were treated with topical application of CS-HA on one eye and CsA on the other 4 times a day for 6-8 weeks. BUT, Schirmer's test without anesthesia, and conjunctival impression cytology (CIC; goblet cell density, nucleus to cytoplasmic ratio, and epithelial cell morphology) were evaluated and compared between eyes before and after treatment (repeated measurement of ANOVA).

Results: After treatment, BUT and tear wettings were significantly prolonged in each group. Topical CsA treated eyes had greater increase in BUT (p=0.026); there was no significant difference in tear wetting (p=0.132). While the 3 parameters of CIC improved in both groups, goblet cell density was significantly higher in eyes treated with CsA (p=0.033).

Conclusions: While both CS-HA and 0.05% CsA eyedrops improve ocular surfaces, topical CsA may have a better effect on enhancing tear film stability and goblet cell density.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Administration, Topical
  • Cell Count
  • Chondroitin Sulfates / administration & dosage*
  • Conjunctiva / drug effects
  • Conjunctiva / pathology
  • Cyclosporine / administration & dosage*
  • Drug Administration Schedule
  • Drug Combinations
  • Drug Therapy, Combination
  • Dry Eye Syndromes / drug therapy*
  • Dry Eye Syndromes / metabolism
  • Dry Eye Syndromes / pathology
  • Epithelium / drug effects
  • Epithelium / pathology
  • Female
  • Follow-Up Studies
  • Goblet Cells / drug effects
  • Goblet Cells / pathology
  • Humans
  • Hyaluronic Acid / administration & dosage*
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Middle Aged
  • Ophthalmic Solutions / administration & dosage
  • Tears / drug effects
  • Tears / metabolism
  • Time Factors
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Drug Combinations
  • Immunosuppressive Agents
  • Ophthalmic Solutions
  • Cyclosporine
  • Hyaluronic Acid
  • Chondroitin Sulfates